EA
CAH icon

Evolution Advisers’s Cardinal Health CAH Stock Holding History

Evolution Advisers’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+2
New +$416 ﹤0.01% 314

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Evolution Advisers's CAH Position: Q2 2026 in Review

Evolution Advisers opened a new position in Cardinal Health (CAH) in Q2 2026: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #314 among its holdings.

1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Evolution Advisers held 2 shares of Cardinal Health worth $0 as of Q2 2026.
  • Cardinal Health was a new Evolution Advisers position in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #314 holding.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.